Long on ACAD - Upgraded Target to $35.00 level Long

ACADIA Pharmaceuticals Inc.NASDAQ

Description

⋅ Mar 8, 2014 6:32 AM

This is more of a personal play as I have been long since the stock was trading below $3.00. There is a strong possibility this recent test of support, just below the $27.00 level, initiates the continuation of the price climb.